MDX-1411
MDX-1411 is a fully human monoclonal antibody targeting CD70. MDX-1411 is capable of inducing antibody-dependent cellular cytotoxicity (ADCC) . MDX-1411 can be used in the research of B-cell malignancies[1].
Product Specifications
CAS Number
2101467-47-2
UNSPSC
12352203
Target
Transmembrane Glycoprotein
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
References & Citations
[1]Quintás-Cardama A, et al. Investigational immunotherapeutics for B-cell malignancies. J Clin Oncol. 2010 Feb 10;28 (5) :884-92.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog